Literature DB >> 7724594

Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells.

M Vitale1, S Sivori, D Pende, L Moretta, A Moretta.   

Abstract

In the present study, we define a group of natural killer (NK) clones (group 0) that fails to lyse all of the normal allogeneic target cells analyzed. Their specificity for HLA class I molecules was suggested by their ability to lyse class I-negative target cells and by the fact that they could lyse resistant target cells in the presence of selected anti-class I monoclonal antibodies. The use of appropriate target cells represented by either HLA-homozygous cell lines or cell transfectants revealed that these clones recognized all the HLA-C alleles. By the use of monoclonal antibodies directed to either GL183 or EB6 molecules, we showed that the EB6 molecules were responsible for the recognition of Cw4 and related alleles, while the GL183 molecules recognized Cw3 (and related C alleles). These data suggest that the GL183 and the EB6 molecules can function, in individual NK clones, as independent receptors for two different groups of HLA-C alleles, (which include all known alleles for locus C), thus resulting in their inability to lyse all normal HLA-C+ target cells. Indirect immunofluorescence and fluorescence-activated cell sorting analysis revealed that the presently defined GL183+EB6+ group 0 NK clones brightly express EB6 molecules (EB6bright) while the GL183+EB6+ group 2 clones (unable to recognize Cw4) express an EB6dull phenotype. These data also imply that the density of EB6 receptors may be critical for the generation of an optimal negative signal upon interaction with appropriate HLA-C alleles.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7724594      PMCID: PMC42202          DOI: 10.1073/pnas.92.8.3536

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  To thine own self be true...

Authors:  C A Janeway
Journal:  Curr Biol       Date:  1991-08       Impact factor: 10.834

2.  An unexpected petition for pardon.

Authors:  K Kärre
Journal:  Curr Biol       Date:  1992-11       Impact factor: 10.834

3.  NK susceptibility varies inversely with target cell class I HLA antigen expression.

Authors:  W J Storkus; D N Howell; R D Salter; J R Dawson; P Cresswell
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

4.  Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2).

Authors:  E Ciccone; D Pende; O Viale; A Than; C Di Donato; A M Orengo; R Biassoni; S Verdiani; A Amoroso; A Moretta
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

5.  Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene.

Authors:  M Colonna; T Spies; J L Strominger; E Ciccone; A Moretta; L Moretta; D Pende; O Viale
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

6.  A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.

Authors:  A Moretta; G Tambussi; C Bottino; G Tripodi; A Merli; E Ciccone; G Pantaleo; L Moretta
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

7.  Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles.

Authors:  A Moretta; M Vitale; S Sivori; C Bottino; L Morelli; R Augugliaro; M Barbaresi; D Pende; E Ciccone; M Lopez-Botet; L Moretta
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

8.  Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: ancestral haplotypes encode particular NK-defined haplotypes.

Authors:  F T Christiansen; C S Witt; E Ciccone; D Townend; D Pende; D Viale; L J Abraham; R L Dawkins; L Moretta
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

9.  Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor.

Authors:  C Bottino; G Tambussi; S Ferrini; E Ciccone; P Varese; M C Mingari; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

10.  P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.

Authors:  A Moretta; M Vitale; C Bottino; A M Orengo; L Morelli; R Augugliaro; M Barbaresi; E Ciccone; L Moretta
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  17 in total

1.  Natural killer cell-produced IFN-γ and TNF-α induce target cell cytolysis through up-regulation of ICAM-1.

Authors:  Ruipeng Wang; Jessica J Jaw; Nicole C Stutzman; Zhongcheng Zou; Peter D Sun
Journal:  J Leukoc Biol       Date:  2011-11-01       Impact factor: 4.962

Review 2.  Innate immune control of HIV.

Authors:  Mary Carrington; Galit Alter
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

3.  HLA class I and class II frequencies in patients with cutaneous malignant melanoma from southeastern Spain: the role of HLA-C in disease prognosis.

Authors:  José A Campillo; Jorge A Martínez-Escribano; Manuel Muro; Rosa Moya-Quiles; Luis A Marín; Olga Montes-Ares; Natalia Guerra; Paloma Sánchez-Pedreño; José F Frías; José A Lozano; Ana M García-Alonso; M Rocío Alvarez-López
Journal:  Immunogenetics       Date:  2005-12-20       Impact factor: 2.846

4.  Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones.

Authors:  M Vitale; S Sivori; D Pende; R Augugliaro; C Di Donato; A Amoroso; M Malnati; C Bottino; L Moretta; A Moretta
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

5.  Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule.

Authors:  Q R Fan; D N Garboczi; C C Winter; N Wagtmann; E O Long; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 6.  HLA-C revisited. Ten years of change.

Authors:  C S Falk; D J Schendel
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

Review 7.  Natural killer cell receptors specific for major histocompatibility complex class I molecules.

Authors:  W M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

8.  Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor.

Authors:  D N Burshtyn; A M Scharenberg; N Wagtmann; S Rajagopalan; K Berrada; T Yi; J P Kinet; E O Long
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

Review 9.  Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias.

Authors:  A Moretta; D Pende; F Locatelli; L Moretta
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

10.  Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors.

Authors:  Nicolas F Delahaye; Sylvie Rusakiewicz; Isabelle Martins; Cédric Ménard; Stephan Roux; Luc Lyonnet; Pascale Paul; Matthieu Sarabi; Nathalie Chaput; Michaela Semeraro; Véronique Minard-Colin; Vichnou Poirier-Colame; Kariman Chaba; Caroline Flament; Véronique Baud; Hélène Authier; Saadia Kerdine-Römer; Marc Pallardy; Isabelle Cremer; Laetitia Peaudecerf; Bénédita Rocha; Dominique Valteau-Couanet; Javier Celis Gutierrez; Jacques A Nunès; Frédéric Commo; Sylvie Bonvalot; Nicolas Ibrahim; Philippe Terrier; Paule Opolon; Cristina Bottino; Alessandro Moretta; Jan Tavernier; Pascal Rihet; Jean-Michel Coindre; Jean-Yves Blay; Nicolas Isambert; Jean-François Emile; Eric Vivier; Axel Lecesne; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2011-05-08       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.